Fidelity Investments’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $80.1K | Buy |
10,892
+10,516
| +2,797% | +$77.3K | ﹤0.01% | 3698 |
|
2025
Q1 | $2.9K | Sell |
376
-880
| -70% | -$6.79K | ﹤0.01% | 4825 |
|
2024
Q4 | $15.2K | Sell |
1,256
-2,486
| -66% | -$30.1K | ﹤0.01% | 4296 |
|
2024
Q3 | $46.9K | Buy |
+3,742
| New | +$46.9K | ﹤0.01% | 3799 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 5474 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 5394 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 4603 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 4633 |
|
2021
Q2 | – | Sell |
-11
| Closed | – | – | 4512 |
|
2021
Q1 | $0 | Hold |
11
| – | – | ﹤0.01% | 4213 |
|
2020
Q4 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 3691 |
|
2015
Q4 | – | Sell |
-350
| Closed | -$184K | – | 2745 |
|
2015
Q3 | $184K | Sell |
350
-372
| -52% | -$196K | ﹤0.01% | 2687 |
|
2015
Q2 | $1.59M | Buy |
722
+63
| +10% | +$138K | ﹤0.01% | 2481 |
|
2015
Q1 | $1.54M | Sell |
659
-16
| -2% | -$37.4K | ﹤0.01% | 2454 |
|
2014
Q4 | $1.4M | Buy |
675
+15
| +2% | +$31.1K | ﹤0.01% | 2488 |
|
2014
Q3 | $1.31M | Buy |
660
+164
| +33% | +$327K | ﹤0.01% | 2495 |
|
2014
Q2 | $1.76M | Sell |
496
-31
| -6% | -$110K | ﹤0.01% | 2422 |
|
2014
Q1 | $1.97M | Sell |
527
-19
| -3% | -$71.1K | ﹤0.01% | 2386 |
|
2013
Q4 | $1.78M | Buy |
546
+16
| +3% | +$52.2K | ﹤0.01% | 2371 |
|
2013
Q3 | $2.22M | Sell |
530
-5,384
| -91% | -$22.5M | ﹤0.01% | 2325 |
|
2013
Q2 | $19.9M | Buy |
+5,914
| New | +$19.9M | ﹤0.01% | 1666 |
|